|
PCRX | Pacira Biosciences, Inc. |
|
|
PCRX | Pacira Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.99 |
| Leverage | 49.82% |
| Market Cap | $ 1.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -103.9m |
| Margin | -20.06% |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.